116 related articles for article (PubMed ID: 2214181)
1. [One-year remission of chronic myelogenous leukemia (CML) after discontinuation of interferon-alpha].
Kobayashi Y; Kimura S; Tanaka K; Kimura S; Wada K; Ozawa M; Maruo N; Kondo M
Rinsho Ketsueki; 1990 Jul; 31(7):1013-6. PubMed ID: 2214181
[TBL] [Abstract][Full Text] [Related]
2. [Intermittent administration of natural interferon-alpha for over 5 years induced complete suppression of Philadelphia chromosome in a patient with myelogenous leukemia].
Koyama S; Aoki S; Furukawa T; Takahashi M; Kishi K; Koike T; Moriyama Y; Hattori A; Shibata A
Rinsho Ketsueki; 1991 Dec; 32(12):1577-9. PubMed ID: 1779460
[TBL] [Abstract][Full Text] [Related]
3. [Natural interferon-alpha induced cytogenetic complete remission in a patient with chronic myelocytic leukemia, diagnosed in early chronic phase with basophilia and normal blood cell counts].
Koyama S; Moriyama Y; Aoki A; Furukawa T; Narita M; Wada K; Kishi K; Takahashi M; Koike T; Shibata A
Rinsho Ketsueki; 1992 Feb; 33(2):227-31. PubMed ID: 1635174
[TBL] [Abstract][Full Text] [Related]
4. [Thrombocytosis in chronic myelogenous leukemia (CML) controlled by interferon alpha (IFN-alpha)].
Koike G; Otsuka T; Shibuya T; Niho Y
Rinsho Ketsueki; 1989 Mar; 30(3):400-3. PubMed ID: 2769964
[TBL] [Abstract][Full Text] [Related]
5. [Appearance of chromosomally normal hemopoiesis during busulfan-induced remission in a case of Ph1 positive chronic myelogenous leukemia].
Takahira H; Ideguchi H; Hirata J; Nishimura J; Nawata H; Shimizu S
Rinsho Ketsueki; 1989 Feb; 30(2):251-5. PubMed ID: 2746880
[TBL] [Abstract][Full Text] [Related]
6. [Partial and complete disappearance of Ph1 chromosome in two patients with chronic myelogenous leukemia after conventional chemotherapy].
Kitabayashi A; Miura I; Ito T; Takahashi M; Chubachi A; Niitsu H; Mamiya S; Miura AB
Rinsho Ketsueki; 1993 Jun; 34(6):733-7. PubMed ID: 8366576
[TBL] [Abstract][Full Text] [Related]
7. [Disappearance of Philadelphia chromosomes after remission induction in lymphoid crisis of chronic myelogenous leukemia].
Nagafuji K; Iwakiri R; Miyamoto T; Okamura H; Yokota E; Matsumoto I
Rinsho Ketsueki; 1992 Sep; 33(9):1226-30. PubMed ID: 1433945
[TBL] [Abstract][Full Text] [Related]
8. [Chronic myelocytic leukemia induced into remission by interferon-alpha associated with early esophageal cancer].
Annoh S; Umeda M; Arai N; Shikoshi K; Su CY; Yasushi T; Kitazawa Y; Shirai T
Rinsho Ketsueki; 1991 Jul; 32(7):786-90. PubMed ID: 1920843
[TBL] [Abstract][Full Text] [Related]
9. [Chronic myelogenous leukemia maintained in remission by interferon alpha presenting with bladder cancer].
Kobayashi H; Ogawa T
Rinsho Ketsueki; 1989 Jul; 30(7):1093-4. PubMed ID: 2810796
[TBL] [Abstract][Full Text] [Related]
10. [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
Motomura S; Sakai R; Tomita N; Fujimaki K; Hattori M; Fujisawa S; Mohri H; Takahashi N; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1998 Apr; 39(4):302-7. PubMed ID: 9597898
[TBL] [Abstract][Full Text] [Related]
11. [Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
Yasuyama M; Kawauchi K; Takei K; Ogasawara T; Ohkawa S
Rinsho Ketsueki; 2004 Jan; 45(1):66-71. PubMed ID: 14999937
[TBL] [Abstract][Full Text] [Related]
12. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
[TBL] [Abstract][Full Text] [Related]
13. [Successful treatment with donor leukocyte transfusion followed by interferon-alpha in a patient with relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation].
Maeda A; Yamamoto K; Kotone Y; Yamashita K; Yoshinaga N; Hirata H; Asagoe K; Nohgawa M; Takahashi A; Ohno H; Tashima M; Sasada M
Rinsho Ketsueki; 1998 Jun; 39(6):442-6. PubMed ID: 9695673
[TBL] [Abstract][Full Text] [Related]
14. [Discrepancy in karyotypes between peripheral blood and bone marrow during blastic crisis in chronic myelocytic leukemia].
Maeda T; Ashie T; Kikuiri K; Ishiyama N; Takakura M
Rinsho Ketsueki; 1989 Jul; 30(7):1032-6. PubMed ID: 2810787
[TBL] [Abstract][Full Text] [Related]
15. [Hematologic abnormalities in a patient with chronic myelogenous leukemia with advanced myelofibrosis were improved by G-CSF].
Hiruma K; Saitoh H; Someya K; Kashimura M
Rinsho Ketsueki; 1994 Feb; 35(2):135-41. PubMed ID: 7511182
[TBL] [Abstract][Full Text] [Related]
16. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
Meloni G; Russo D; Baccarani M; Testoni N; Martinelli G; Fanin R; Zuffa E; Rosti G; Alimena G; Saglio G; Mandelli F; Tura S
Haematologica; 1999 Aug; 84(8):707-15. PubMed ID: 10457406
[TBL] [Abstract][Full Text] [Related]
18. Therapy of chronic myelogenous leukaemia with interferons.
Talpaz M; Kurzrock R; Kantarjian H; Gutterman J
Cancer Surv; 1989; 8(4):793-8. PubMed ID: 2701727
[TBL] [Abstract][Full Text] [Related]
19. [Natural interferon alpha for chronic myelogenous leukemia in the chronic phase: hematologic, cytogenetic and molecular response].
Takeuchi J; Kawamura M; Sawada U; Ohshima T; Horie T; Horikoshi A; Abe T
Rinsho Ketsueki; 1995 Oct; 36(10):1149-56. PubMed ID: 8531323
[TBL] [Abstract][Full Text] [Related]
20. [Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma].
Hasegawa A; Ninomiya H; Yanagisawa K; Takada K; Hasegawa H; Hato T; Yasukawa M; Fujita S
Rinsho Ketsueki; 1996 Sep; 37(9):853-7. PubMed ID: 8914475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
